Table 3 Characteristics of selected studies.
From: The effectiveness of computerized clinical guidelines in the process of care: a systematic review
Variables | Countries | |||
|---|---|---|---|---|
| Â | Â | Europe | USA | Oceania |
Study design | Observational | 2 (33.3%) | 4 (66.7%) | 0 (0.0%) |
| Â | Experimental | 9 (23.1%) | 29 (74.3%) | 1 (2.6%) |
Type of patients | Inpatient | 2 (28.6%) | 5 (71.4%) | 0 (0.0%) |
| Â | Outpatient | 4 (23.5%) | 12 (70.6%) | 1 (5.9%) |
Guidelines receivers | Physicians | 10(28.6%) | 24 (68.6%) | 1 (2.9%) |
| Â | Other care givers | 1 (10.0%) | 9 (90.0%) | 0 (0%) |
Population of study | Simulated | 1 (25.0%) | 3 (75.0%) | 0 (0.0%) |
| Â | Real | 10(24.4%) | 30 (73.2%) | 1 (3.3%) |
Type of centres involved in the study | Non--academic | 5 (22.7%) | 17 (77.3%) | 0 (0.0%) |
| Â | Academic | 5 (25.0%) | 15 (75.0%) | 0 (0.0%) |
Number of centres involved in the study | Multicentric | 7 (36.8%) | 11 (57.9%) | 1 (5.3%) |
| Â | Monocentric | 4 (15.4%) | 22 (84.6%) | 0 (0.0%) |
Type of guideline | Preventive | 1 (7.1%) | 12 (85.7%) | 1 (7.1%) |
| Â | Treatment | 9 (32.1%) | 19 (67.9%) | 0 (0.0%) |
| Â | Both | 1 (33.3%) | 2 (66.7%) | 0 (0.0%) |
Type of condition | Acute | 2 (28.6%) | 5 (71.4) | 0 (0.0%) |
| Â | Chronic | 6 (22.2%) | 21 (77.8%) | 0 (0.0%) |
| Â | Both | 3 (27.3%) | 7 (63.6%) | 1 (9.1%) |
Type of intervention | Test or/and drugs | 7 (29.2%) | 17 (70.8%) | 0 (0.0%) |
| Â | Other intervention | 1 (14.3%) | 6 (85.7%) | 0 (0.0%) |
| Â | Both | 3 (21.4%) | 10 (71.4) | 1 (7.1%) |